Muscle Relaxant Selection for Patients on Calcium Supplements

Introduction to Muscle Relaxants

The American Heart Association suggests that routine calcium supplementation does not interfere with muscle relaxant pharmacology, as there are no clinically significant interactions between calcium supplementation and neuromuscular blocking agents or skeletal muscle relaxants 1

For rapid sequence intubation or short procedures, the American Society of Anesthesiologists recommends rocuronium as the preferred non-depolarizing agent, dosed at 0.6-1.2 mg/kg based on lean body weight, with sugammadex available for reversal 2, 3, 4
The American Society of Anesthesiologists also recommends succinylcholine as the gold standard for rapid onset, particularly when contraindications are absent, dosed at 1.0 mg/kg based on actual body weight 2, 3, 4
Non-depolarizing agents, such as rocuronium, vecuronium, pancuronium, and atracurium, should be dosed based on lean body weight, not actual body weight, according to the American Society of Anesthesiologists 2, 3, 4
Neuromuscular monitoring is essential to guide reversal agent dosing and prevent recurarization, as recommended by the American Heart Association 1, 2

The European Society of Anaesthesiology recommends sugammadex dosing depends on depth of blockade: 2.0 mg/kg for moderate, 4.0 mg/kg for deep, or 8.0 mg/kg for immediate reversal 5
The European Society of Anaesthesiology also notes that efficacy of sugammadex may be reduced in elderly patients and those with severe renal failure (creatinine clearance <30 mL/min) 2, 4, 5

For elderly or renally impaired patients, the American Academy of Neurology recommends baclofen as the preferred oral agent, starting at 5 mg three times daily, with maximum tolerated dose typically 30-40 mg/day 6
The American Academy of Neurology also recommends tizanidine as an alternative, starting at 2 mg three times daily, with careful monitoring for orthostatic hypotension and sedation 6

The American Heart Association warns against confusing calcium supplementation with calcium administration for toxicity reversal, where specific muscle relaxant considerations apply 1
The American Academy of Neurology advises against abrupt discontinuation of baclofen due to risk of withdrawal symptoms, including CNS irritability 6
The American Geriatrics Society recommends avoiding combination of muscle relaxants with other anticholinergic medications in elderly patients 6
The American Geriatrics Society also recommends using the shortest duration and lowest effective dose in elderly patients 6
The American Society of Anesthesiologists emphasizes the importance of monitoring neuromuscular function when using anesthetic muscle relaxants to ensure complete reversal and prevent residual blockade 1, 2, 5